INS and obesity due to melanocortin 4 receptor deficiency: In metabolic diseases such as type 2 diabetes mellitus (T2DM) and obesity, BBR has been shown to coordinate responses at multiple molecular levels, restoring metabolic balance, reducing inflammation, and improving insulin sensitivity [106,107,108].